MDGL 250117 165.00P (MDGL250117P165000) Stock Options, News & Quotes

US OptionsDetailed Quotes

MDGL250117P165000

Watchlist

10.00
0.000.00%

15min DelayTrading Oct 4 14:51 ET

0.00High0.00Low

Intraday

5D
Daily

News

Leerink Partners Maintains Madrigal Pharmaceuticals(MDGL.US) With Buy Rating, Maintains Target Price $390
Moomoo NewsDec 18 01:31 ET · Ratings
Sagimet Started at Outperform by Oppenheimer, MASH Drug Cited
Seeking AlphaDec 6 13:56 ET
Madrigal Pharmaceuticals Price Target Raised to $427 From $415 at JMP Securities
Yahoo FinanceDec 6 06:46 ET
Insider Sale: Director at $MDGL (MDGL) Sells 520 Shares
Quiver QuantitativeDec 5 17:01 ET
Madrigal Pharmaceuticals Insider Sold Shares Worth $1,135,122, According to a Recent SEC Filing
MT NewswiresDec 5 16:51 ET
Madrigal Pharmaceuticals, Inc.'s (NASDAQ:MDGL) Path To Profitability
Simply Wall StDec 3 05:09 ET

Comments

Stock_Drift

Nov 1 10:33

Unusual Volume Ticks. 11:32am

$Madrigal Pharmaceuticals (MDGL.US)$ $Nuburu (BURU.US)$ $Pro-Dex (PDEX.US)$ $ASP Isotopes (ASPI.US)$ $GRI Bio (GRI.US)$ $Vast Renewables (VSTE.US)$ $MicroCloud Hologram (HOLO.US)$ $Theriva Biologics (TOVX.US)$ $Pluribus Technologies Corp (PLRB.CA)$ $Ensysce Biosciences (ENSC.US)$ $Athira (ATHA.US)$ $Globalstar (GSAT.US)$ $ChromaDex (CDXC.US)$
📊⚡️📊

Jerry Kronenberg

Jun 11 14:52

Columns Madrigal Pharmaceuticals Rallies 15% on Wolfe Research 'Outperform' Rating

$Madrigal Pharmaceuticals (MDGL.US)$ rose some 15% Tuesday after Wolfe Research reportedly initiated coverage of the pharma firm with a "Outperform" rating.
MDGL gained as much as 15.2% to a $294.44 intraday high after Wolfe lauded the company's breakthrough liver drug Rezdiffra, according to published reports.
The U.S. Food and Drug Administration approved Rezdiffra in March as the first treatment fornonalcoholic steatoh...

Meltyy

May 16 01:29

🔔 Perceptive Advisors Q1 ‘24* Holdings Released... 🐳

» Holdings: 112
» Holdings in Top 20: 58.46%
» Qtr over Qtr Change**: 28.47%
Top Holdings:
$Cerevel Therapeutics Holdings (CERE.US)$
$Amicus Therapeutics (FOLD.US)$
$Iovance Biotherapeutics (IOVA.US)$
$Arcellx (ACLX.US)$
$Nuvalent (NUVL.US)$
$Apogee Therapeutics (APGE.US)$
$Inhibrx (INBX.US)$
$Fusion Pharmaceuticals (FUSN.US)$
$Rhythm Pharmaceuticals (RYTM.US)$
$Vaxcyte (PCVX.US)$
$Soleno Therapeutics (SLNO.US)$
$Medtronic (MDT.US)$
$Madrigal Pharmaceuticals (MDGL.US)$
...

Meltyy

May 16 01:14

🔔 Baker Bros. Q1 ‘24* Holdings Released... 🐳

» Holdings: 87
» Holdings in Top 20: 86.71%
» Qtr over Qtr Change**: -9.29%
Top Holdings:
$Incyte (INCY.US)$
$BeiGene (BGNE.US)$
$ACADIA Pharmaceuticals (ACAD.US)$
$Madrigal Pharmaceuticals (MDGL.US)$
$Rhythm Pharmaceuticals (RYTM.US)$
$Revolution Medicines (RVMD.US)$
$Kymera Therapeutics (KYMR.US)$
$AbCellera Biologics (ABCL.US)$
$Bicycle Therapeutics (BCYC.US)$
$Edgewise Therapeutics (EWTX.US)$
$Immunocore (IMCR.US)$
$Kodiak Sciences (KOD.US)$
$Roivant Sciences (ROIV.US)$
...

Tao Lao Zoa

May 8 10:07

$Madrigal Pharmaceuticals (MDGL.US)$ Chi chif lao wai cheo? = They block Short why trade 😭😭😭😭😭